CEACAM5 and neoplasm: Therefore, a comprehensive evaluation including radiological surveillance, serum tumor markers (CEA, CA199 and CA125) monitoring, pathological examination, and molecular diagnosis based on genomic and transcriptomic analyses would help identify the potential population that might benefit from immunotherapy.